News Release 2022
- 11.10.2022IR
Earnings briefing materials for 3Q of the fiscal year ending December 2022(PDF:2,318KB)
- 11.10.2022IR
Consolidated Financial Results for the Nine Months Ended September 30, 2022 [JGAAP](PDF:511KB)
- 11.08.2022IR
Notice Concerning Change of Executive Officers(PDF:315KB)
- 11.08.2022IR
Notice Concerning Acquisition of Business(PDF:320KB)
- 09.26.2022IR
[Delayed] Notice Regarding Changes in Organization and Directors(PDF:476KB)
- 08.05.2022IR
Earnings briefing materials for 2Q of the fiscal year ending December 2022(PDF:3,154KB)
- 08.05.2022IR
Consolidated Financial Results for the Six Months Ended June 30, 2022 [JGAAP](PDF:525KB)
- 07.08.2022IR
Notice Regarding Sale of Shares in Taiko Pharmaceutical Co.,Ltd. and Continuation of Business Alliance Agreement(PDF:441KB)
- 05.31.2022Sustainability
Notice Regarding Identification of Materiality Issues and Establishment of Non-Financial KPIs(PDF:1,029KB)
- 05.31.2022IR
Earnings briefing materials for 1Q of the fiscal year ending December 2022(PDF:2,436KB)
- 05.12.2022IR
Consolidated Financial Results for the Three Months Ended March 31, 2022 [JGAAP](PDF:694KB)
- 04.22.2022IR
Notice Regarding Completion of Payment for Disposal of Treasury Stock as Restricted Stock Compensation(PDF:326KB)
- 04.04.2022IR
Update on disclosed matter; Notice regarding the Expansion of Business Development in the Philippines(PDF:328KB)
- 03.28.2022IR
Notice regarding Result and Completion of Acquisition of Own Shares through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)(PDF:132KB)
- 03.25.2022IR
Notice Regarding Acquisition of Own Shares and Repurchase of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)(PDF:135KB)
- 03.25.2022IR
Notice of Disposal of Treasury Stock as Remuneration for Restricted Stock(PDF:355KB)
- 02.14.2022IR
Notice Regarding Change of Directors and Board Members(PDF:350KB)
- 02.14.2022IR
Position and Policy Regarding Reduction in the Trading Unit of the Company’s Shares(PDF:127KB)
- 02.14.2022IR
Matters Concerning Controlling Shareholders, and Others.(PDF:363KB)
- 02.14.2022IR
Notice Regarding Revision of Restricted Stock Compensation Plan(PDF:316KB)
- 02.14.2022IR
Notice Regarding Dividends of Surplus(PDF:325KB)
- 02.14.2022IR
Consolidated Financial Results for the Fiscal Year Ended December 31, 2021 (Japanese GAAP)(PDF:824KB)
- 01.31.2022IR
Notice of Revision of Financial Results and Dividend Forecast for the Full Year for the year ended December 31, 2021 [JGAAP](PDF:332KB)
- 01.11.2022IR
Notice Concerning the Transition to the Prime Market in Tokyo Stock Exchange New Market Segment(PDF:127KB)
Page Top